Hitch in the Haymaker: FTC Request Delays Chesapeake-Southwestern Merger
Chesapeake Energy's merger with Southwestern Energy delayed as FTC requests more info. Expected to be completed in second half of 2024.
JPMorgan Appoints New Leaders To Steer Global Banking Unit: Report
JPMorgan Chase reorganizes leadership in global banking division, appointing new leaders in capital markets and investment banking.
Johnson & Johnson Makes Yet Another Multi-Billion MedTech Deal With Shockwave Medical
Johnson & Johnson to acquire Shockwave Medical for $335.00/share in cash, bolstering its cardiovascular intervention portfolio. The acquisition, expected to close by mid-2024, signifies Johnson & Johnson's strategic focus on innovation and market expansion.
Woodside’s JV Takes Flight: Partners With Yara Pilbara To Capture Carbon
Woodside Energy's Angel CCS JV plans to collaborate with Yara Pilbara to study carbon capture and storage for decarbonizing operations in Australia.
US Regulators Gives Green Light for Enbridge’s Louisiana Venice Pipeline: Report
Enbridge's subsidiary reportedly received FERC approval for Venice extension project in Louisiana with a capacity of 1.3 bcfd and $500M cost. Project expected to be completed by 2026.
Shell’s LNG Trading Update Reveals Surprising Shifts: Details
Shell plc updated its Q1 FY24 outlook, with lower results expected from its LNG trading business. Integrated Gas and marketing outlooks were also adjusted.
Top 10 US High-Yield Corporate Bonds With Returns Over 20% In April 2024
The U.S. high-yield corporate bond market is attracting investors seeking both returns and diversification from stocks. But beware of higher risk.
Arbutus Vs. Moderna Patent Dispute Over Covid-19 Vaccine Gets Response From Judge
Delaware Judge favors Arbutus and Genevant Sciences in their patent dispute with Moderna over COVID-19 vaccine technology.
Why Is Novartis Stock Trading Higher On Thursday?
Novartis to file Pluvicto pre-taxane label expansion in 2H 2024 based on Phase 3 PSMAfore study data. Updated overall survival results show HR<1.0 in ITT population. rPFS consistent. Safety profile remains stable.
Exxon’s Earnings Amidst Oil Price Challenges Has Bright Spots, Says Analyst
Goldman Sachs analyst Neil Mehta notes Exxon Mobil's (NYSE: XOM) projections, indicating higher-than-expected earnings across Upstream, Downstream, and Chemicals segments.